MFIM
TCRT icon

Mesirow Financial Investment Management’s Alaunos Therapeutics TCRT Stock Holding History

Mesirow Financial Investment Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-93
Closed -$990 – 602
2023
Q4 		$990 Buy
+93
New +$1.12K ﹤0.01% 562

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Mesirow Financial Investment Management's TCRT Position: Q1 2024 in Review

Mesirow Financial Investment Management sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 93 shares — an estimated $990 sold.

Mesirow Financial Investment Management first reported a position in TCRT in Q4 2023 and held it in 1 quarter. The position peaked at $990 in Q4 2023. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Mesirow Financial Investment Management reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 93 Alaunos Therapeutics shares in Q1 2024, an estimated $990.
  • Mesirow Financial Investment Management first reported a position in Alaunos Therapeutics in Q4 2023 and held it in 1 quarter.
  • Mesirow Financial Investment Management's Alaunos Therapeutics position peaked at $990 in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Mesirow Financial Investment Management's 13F filing for Q1 2024, filed 19 Apr 2024.